New Key Statistics Module, Z-Score and F-Score
NAS:JAZZ Key Ratios
Market Cap $ M | 6,739.84 |
Enterprise Value $ M | 11,012.37 |
P/E(ttm) | 17.66 |
PE Ratio without NRI | 11.10 |
Forward PE Ratio | 5.81 |
Price/Book | 1.80 |
Price/Sales | 2.03 |
Price/Free Cash Flow | 7.45 |
Price/Owner Earnings | 20.19 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 3,834.00 |
EPS (TTM) $ | 6.12 |
Beneish M-Score | -2.71 |
10-y EBITDA Growth Rate % | 7.10 |
5-y EBITDA Growth Rate % | -1.50 |
y-y EBITDA Growth Rate % | 95.30 |
EV-to-EBIT | 18.75 |
EV-to-EBITDA | 8.98 |
PEG | -- |
Shares Outstanding M | 62.35 |
Net Margin (%) | 10.82 |
Operating Margin % | 15.59 |
Pre-tax Margin (%) | 7.77 |
Quick Ratio | 1.85 |
Current Ratio | 2.24 |
ROA % (ttm) | 3.72 |
ROE % (ttm) | 12.08 |
ROIC % (ttm) | 9.25 |
Dividend Yield % | -- |
Altman Z-Score | 1.35 |
JAZZ Number of Guru Trades
JAZZ Volume of Guru Trades
Gurus Latest Trades with NAS:JAZZ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:JAZZ is held by these investors
Total 4
Jazz Pharmaceuticals PLC Insider Transactions
No Available Data
News about NAS:JAZZ
Total 0- 1